Exclusive special offer and discount title banner vector image

GLOBAL MALE INFERTILITY MARKET FORECAST 2023-2032

SCOPE OF THE REPORT

Global Male Infertility Market by Test Type (DNA Fragmentation Technique, Oxidative Stress Analysis, Microscopic Examination, Sperm Agglutination, Computer-assisted Semen Analysis, Sperm Penetration Assay, Other Test Types) Market by Treatment (Assisted Reproductive Technology and Surgery, Medications) by Geography

REQUEST CUSTOMIZATION

MARKET OVERVIEW

In terms of revenue, the global male infertility market was valued at $4162.92 million in 2022, and is expected to reach $6458.51 million by 2032, growing at a 4.53% CAGR during the forecast period, 2023-2032. The market study has also analyzed the impact of COVID-19 on the market qualitatively as well as quantitatively. 

Male infertility refers to any health condition in a male that reduces the likelihood of his female partner getting pregnant. Most frequently, this is brought on by issues with his sperm delivery or production. Male infertility can be caused by abnormal sperm function, blockages, and low sperm production, which prevents the delivery of sperm. Illnesses, chronic health issues, injuries, lifestyle choices and other factors may also contribute to male infertility.

Read our latest blog on the Male Infertility Market

GROWTH ENABLERS

Key growth enablers of the global male infertility market are:

  • Surging infertility incidences 
  • Assisted reproductive technology adoption
    • Assisted reproductive technology (ART) offers a quick fix to the male facing problems with infertility due to low sperm count, abnormal sperm quality, and poor motility. This procedure is being widely adopted owing to its benefits, such as a higher success rate as compared to medications. 
    • Over the past year, the use of ART has increased significantly globally, making it possible to conceive for many infertile couples. 
    • As per an article published by the European Commission in 2023, ART helped with the birth of over 8 million globally since the introduction of IVF in the 1980s. 
    • Also, nearly 500,000 ART deliveries take place worldwide every year. Most of the procedures are performed in high-income countries and regions, with about one-half in Europe, followed by North America and Asia (Japan).
    • Moreover, according to an article published by BioMed Central in 2020, approximately 0.3% of all infants born every year are conceived using assisted reproductive technology treatments globally.
  • Technological advancements

GROWTH RESTRAINTS

Key growth restraining factors are:

  • High treatment costs 
    • According to the research article published in Biology of Reproduction, 2019, ART is expensive and usually not covered under most health insurance. 
    • Nearly 75% of IVF/ICSI cycles fail, requiring the couples to undergo multiple treatment cycles, further increasing the treatment cost.
    • As per industry sources, infertility clinics in the United States would likely charge between $12,000 and $14,000 for one cycle of IVF as of 2023. 
    • Most clinics treat certain steps in the IVF process as add-ons to the base cost, some of which are obligatory and others optional. Depending on the needs, a single IVF round may cost $30,000 or more.

To Know More About This Report, Request a Free Sample Copy

KEY MARKET TRENDS

Global Male Infertility Market | Top Trends
  • Increasing acceptance of minimally invasive surgeries
    • Today’s assisted reproductive technology procedures range from the relatively less invasive gamete intra-fallopian transfer (GIFT) and intra-uterine insemination (IUI) to direct injection of a sperm into an ovum (ICSI), followed by culturing, with or without subsequent embryo freezing and thawing. Some steps are outpatient and minimally invasive procedures that take less than 15 minutes. Also, minimally invasive surgical procedure facilitates the production of normal pregnancies by injecting a single sperm (intra-oocyte), which assists in treating severe male infertility. 
  • Growing availability of numerous infertility treatment drugs, procedures, and devices
    • There is an availability of a range of infertility treatment drugs, procedures, and devices, which are being used for male infertility treatment across the globe. Healthcare professionals may recommend medications capable of correcting hormonal imbalances to manage male infertility. If problems with sperm are causing infertility, the doctor may recommend assisted reproductive techniques, such as in vitro fertilization (IVF) or intrauterine insemination (IUI). Infertility specialists perform these procedures at fertility clinics and fertility centers worldwide.
  • Government initiatives toward improving reimbursement scenarios for infertility-related treatments
    • Governments of different countries across the globe are supporting male infertility treatment by launching initiatives to improve reimbursement scenarios for infertility-related treatments. This is expected to contribute towards the market growth during the forecast period. The Centers for Medicare and Medicaid Services approves diagnostic tools and determines reimbursement for assisted reproductive technology (ART) procedures. Less than 20% of the couples receive reimbursement for such expensive treatment. Since patients bear the majority of the costs, efforts are being made to increase insurance coverage.

MARKET SEGMENTATION

Market Segmentation – Test Type and Treatment –Market by Test Type:
  • DNA Fragmentation Technique
    • DNA Fragmentation Technique is expected to dominate the market by test type during the forecast period. Male infertility can be identified using DNA fragmentation when one or both chromosomes in the sperm change nucleotide composition or a physical break. According to numerous studies, infertile males are more likely to experience sperm DNA damage, which results in unfavorable reproductive results. This DNA fragmentation approach is a promising new way to evaluate fertility. So, in particular clinical situations, sperm DNA fragmentation (SDF) tests are also used as adjunct test to traditional semen analysis.
  • Oxidative Stress Analysis
  • Microscopic Examination
  • Sperm Agglutination
  • Computer-Assisted Semen Analysis
  • Sperm Penetration Assay
  • Other Test Types
Market by Treatment:
  • Assisted Reproductive Technology and Surgery
    • Assisted Reproductive Technology and Surgery is expected to be the fastest-growing segment by treatment during the forecast period. Assisted reproductive technology (ART) includes medical procedures used primarily to address infertility. IntraCytoplasmic Sperm Injection (ICSI), in vitro fertilization (IVF), cryopreservation, Preimplantation Genetic Diagnosis (PGD), frozen oocyte replacement, and Intrauterine Insemination (IUI) are a few of the treatments included in ART. ARTs like ICSI and IUI can be used to treat male factor infertility. 
  • Medications

GEOGRAPHICAL STUDY

Geographical Study Based on Four Major Regions:
  • North America: The United States and Canada
  • Europe: The United Kingdom, Germany, France, Italy, Spain, Belgium, Poland, and Rest of Europe
  • Asia-Pacific: China, Japan, India, South Korea, Indonesia, Thailand, Vietnam, Australia & New Zealand, and Rest of Asia-Pacific
    • Asia-Pacific is the most lucrative region and is expected to witness the highest CAGR in the global male infertility market during the forecast period. 
    • Some of the factors that are projected to drive the market in Asia-Pacific include increasing disposable income, rising awareness regarding male infertility, technological advancements, and a range of collaborations & strategic agreements in the Asia-Pacific male infertility market.
    • The region also witnessed the launch of fertility clinics which is expected to supplement the market growth in the region during the forecast period.
  • Rest of World: Latin America, the Middle East & Africa

MAJOR PLAYERS

The major players in the global male infertility market are:

  • Andrology Solutions
  • Aytu BioPharma
  • Bayer Group
  • EMD Serono Inc (Merck Serono)
  • Endo International PLC
  • Halotech DNA
  • Theramex
  • Vitrolife

Key strategies adopted by some of these companies:

  • In January 2023, BUZUD (Singapore’s leading manufacturer of medical devices and appliances) launched a sperm test for male fertility to perform self-testing. Male fertility sperm test is designed and produced in 2 configurations, including strip type and cassette type, and is an easy, fast, and reliable self-testing kit that allows the user to conduct the test at their comfort and convenience. 
  • In February 2023, Posterity Health joined forces with frame fertility to offer new methods to approach fertility challenges while encouraging male assessment early in the family-building process. This is a significant step towards ensuring that males have equal access to fertility resources.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2023-2032
Base Year2022
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million)
Segments AnalyzedTest Type and Treatment
Geographies AnalyzedNorth America, Europe, Asia-Pacific, and Rest of World
Companies AnalyzedAdvaCare Pharma USA, Andrology Solutions, Aytu BioPharma, Bayer Group, Caerus Biotech, CinnaGen Co, EMD Serono Inc (Merck Serono), Endo International PLC, Halotech DNA, Laboratory Corporation of America Holdings, Sanofi, SCSA Diagnostics, Theramex, Vitrolife, Zydus Lifesciences Ltd (Cadila Healthcare Ltd)

TABLE OF CONTENT

  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
    3. SCOPE OF STUDY
    4. CRISIS SCENARIO ANALYSIS
    5. MAJOR MARKET FINDINGS
      1. PRODUCT DEVELOPMENTS AND LAUNCHES BY MARKET PLAYERS PROMOTE MARKET GROWTH
      2. PREVALENCE OF DIABETES AND CANCER
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. SURGING INFERTILITY INCIDENCES 
      2. ASSISTED REPRODUCTIVE TECHNOLOGY ADOPTION
      3. TECHNOLOGICAL ADVANCEMENTS
    2. KEY RESTRAINTS
      1. HIGH TREATMENT COSTS
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
    2. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    3. GROWTH PROSPECT MAPPING
    4. MARKET MATURITY ANALYSIS
    5. MARKET CONCENTRATION ANALYSIS
  5. MARKET BY TEST TYPE
    1. DNA FRAGMENTATION TECHNIQUE
    2. OXIDATIVE STRESS ANALYSIS
    3. MICROSCOPIC EXAMINATION
    4. SPERM AGGLUTINATION
    5. COMPUTER-ASSISTED SEMEN ANALYSIS
    6. SPERM PENETRATION ASSAY
    7. OTHER TEST TYPES
  6. MARKET BY TREATMENT
    1. ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY
    2. MEDICATIONS
  7. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. NORTH AMERICA MALE INFERTILITY MARKET DRIVERS
      3. NORTH AMERICA MALE INFERTILITY MARKET CHALLENGES
      4. KEY PLAYERS IN NORTH AMERICA MALE INFERTILITY MARKET
      5. COUNTRY ANALYSIS
        1. UNITED STATES
          1. UNITED STATES MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
        2. CANADA
          1. CANADA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
    2. EUROPE
      1. MARKET SIZE & ESTIMATES
      2. EUROPE MALE INFERTILITY MARKET DRIVERS
      3. EUROPE MALE INFERTILITY MARKET CHALLENGES
      4. KEY PLAYERS IN EUROPE MALE INFERTILITY MARKET
      5. COUNTRY ANALYSIS
        1. UNITED KINGDOM
          1. UNITED KINGDOM MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
        2. GERMANY
          1. GERMANY MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
        3. FRANCE
          1. FRANCE MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
        4. ITALY
          1. ITALY MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
        5. SPAIN
          1. SPAIN MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
        6. BELGIUM
          1. BELGIUM MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
        7. POLAND
          1. POLAND MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
        8. REST OF EUROPE
          1. REST OF EUROPE MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
    3. ASIA-PACIFIC
      1. MARKET SIZE & ESTIMATES
      2. ASIA-PACIFIC MALE INFERTILITY MARKET DRIVERS
      3. ASIA-PACIFIC MALE INFERTILITY MARKET CHALLENGES
      4. KEY PLAYERS IN ASIA-PACIFIC MALE INFERTILITY MARKET
      5. COUNTRY ANALYSIS
        1. CHINA
          1. CHINA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
        2. JAPAN
          1. JAPAN MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
        3. INDIA
          1. INDIA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
        4. SOUTH KOREA
          1. SOUTH KOREA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
        5. INDONESIA
          1. INDONESIA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
        6. THAILAND
          1. THAILAND MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
        7. VIETNAM
          1. VIETNAM MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
        8. AUSTRALIA & NEW ZEALAND
          1. AUSTRALIA & NEW ZEALAND MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
        9. REST OF ASIA-PACIFIC
          1. REST OF ASIA-PACIFIC MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
    4. REST OF WORLD
      1. MARKET SIZE & ESTIMATES
      2. REST OF WORLD MALE INFERTILITY MARKET DRIVERS
      3. REST OF WORLD MALE INFERTILITY MARKET CHALLENGES
      4. KEY PLAYERS IN REST OF WORLD MALE INFERTILITY MARKET
      5. REGIONAL ANALYSIS
        1. LATIN AMERICA
          1. LATIN AMERICA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
        2. MIDDLE EAST & AFRICA
          1. MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  8. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS
    2. COMPANY PROFILES
      1. ADVACARE PHARMA USA
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
      2. ANDROLOGY SOLUTIONS
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
      3. AYTU BIOPHARMA
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES
      4. BAYER GROUP
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES
      5. CAERUS BIOTECH
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
      6. CINNAGEN CO
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES
      7. EMD SERONO INC (MERCK SERONO)
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES
      8. ENDO INTERNATIONAL PLC
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES
      9. HALOTECH DNA
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
      10. LABORATORY CORPORATION OF AMERICA HOLDINGS
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES
      11. SANOFI
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES
      12. SCSA DIAGNOSTICS
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
      13. THERAMEX
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
      14. VITROLIFE
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES
      15. ZYDUS LIFESCIENCES LTD (CADILA HEALTHCARE LTD)
        1. COMPANY OVERVIEW
        2. PRODUCTS / SERVICES LIST
        3. STRENGTHS & CHALLENGES

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – MALE INFERTILITY

TABLE 2: GLOBAL MALE INFERTILITY MARKET, BY TEST TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3: GLOBAL MALE INFERTILITY MARKET, BY TEST TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 4: GLOBAL DNA FRAGMENTATION TECHNIQUE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: GLOBAL DNA FRAGMENTATION TECHNIQUE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 6: GLOBAL OXIDATIVE STRESS ANALYSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7: GLOBAL OXIDATIVE STRESS ANALYSIS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 8: GLOBAL MICROSCOPIC EXAMINATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 9: GLOBAL MICROSCOPIC EXAMINATION MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 10: GLOBAL SPERM AGGLUTINATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 11: GLOBAL SPERM AGGLUTINATION MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 12: GLOBAL COMPUTER-ASSISTED SEMEN ANALYSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 13: GLOBAL COMPUTER-ASSISTED SEMEN ANALYSIS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 14: GLOBAL SPERM PENETRATION ASSAY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 15: GLOBAL SPERM PENETRATION ASSAY MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 16: GLOBAL OTHER TEST TYPES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 17: GLOBAL OTHER TEST TYPES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 18: GLOBAL MALE INFERTILITY MARKET, BY TREATMENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 19: GLOBAL TREATMENT MARKET, BY TREATMENT, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 20: GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 21: GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 22: GLOBAL MEDICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 23: GLOBAL MEDICATIONS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 24: GLOBAL MALE INFERTILITY MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 25: GLOBAL MALE INFERTILITY MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 26: NORTH AMERICA MALE INFERTILITY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 27: NORTH AMERICA MALE INFERTILITY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 28: KEY PLAYERS OPERATING IN NORTH AMERICA MALE INFERTILITY MARKET

TABLE 29: EUROPE MALE INFERTILITY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 30: EUROPE MALE INFERTILITY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 31: KEY PLAYERS OPERATING IN EUROPE MALE INFERTILITY MARKET

TABLE 32: ASIA-PACIFIC MALE INFERTILITY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 33: ASIA-PACIFIC MALE INFERTILITY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 34: KEY PLAYERS OPERATING IN ASIA-PACIFIC MALE INFERTILITY MARKET

TABLE 35: REST OF WORLD MALE INFERTILITY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 36: REST OF WORLD MALE INFERTILITY MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 37: KEY PLAYERS OPERATING IN REST OF WORLD MALE INFERTILITY MARKET

TABLE 38: LIST OF MERGERS & ACQUISITIONS

TABLE 39: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 40: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 41: LIST OF BUSINESS EXPANSIONS

LIST OF FIGURES 

FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

FIGURE 2: GROWTH PROSPECT MAPPING FOR UNITED STATES

FIGURE 3: GROWTH PROSPECT MAPPING FOR SPAIN

FIGURE 4: GROWTH PROSPECT MAPPING FOR SOUTH KOREA

FIGURE 5: GROWTH PROSPECT MAPPING FOR MIDDLE EAST & AFRICA

FIGURE 6: MARKET MATURITY ANALYSIS

FIGURE 7: MARKET CONCENTRATION ANALYSIS

FIGURE 8: GLOBAL MALE INFERTILITY MARKET, GROWTH POTENTIAL, BY TEST TYPE, IN 2022

FIGURE 9: GLOBAL MALE INFERTILITY MARKET, BY DNA FRAGMENTATION TECHNIQUE, 2023-2032 (IN $ MILLION)

FIGURE 10: GLOBAL MALE INFERTILITY MARKET, BY DNA FRAGMENTATION TECHNIQUE, 2023-2032 (IN $ MILLION)

FIGURE 11: GLOBAL MALE INFERTILITY MARKET, BY OXIDATIVE STRESS ANALYSIS, 2023-2032 (IN $ MILLION)

FIGURE 12: GLOBAL MALE INFERTILITY MARKET, BY MICROSCOPIC EXAMINATION, 2023-2032 (IN $ MILLION)

FIGURE 13: GLOBAL MALE INFERTILITY MARKET, BY SPERM AGGLUTINATION, 2023-2032 (IN $ MILLION)

FIGURE 14: GLOBAL MALE INFERTILITY MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS, 2023-2032 (IN $ MILLION)

FIGURE 15: GLOBAL MALE INFERTILITY MARKET, BY SPERM PENETRATION ASSAY, 2023-2032 (IN $ MILLION)

FIGURE 16: GLOBAL MALE INFERTILITY MARKET, BY OTHER TEST TYPES, 2023-2032 (IN $ MILLION)

FIGURE 17: GLOBAL TREATMENT MARKET, GROWTH POTENTIAL, BY TREATMENT, IN 2022

FIGURE 18: GLOBAL MALE INFERTILITY MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY, 2023-2032 (IN $ MILLION)

FIGURE 19: GLOBAL MALE INFERTILITY MARKET, BY MEDICATIONS, 2023-2032 (IN $ MILLION)

FIGURE 20: NORTH AMERICA MALE INFERTILITY MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 21: UNITED STATES MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 22: CANADA MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 23: EUROPE MALE INFERTILITY MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 24: UNITED KINGDOM MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 25: GERMANY MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 26: FRANCE MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 27: ITALY MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 28: SPAIN MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 29: BELGIUM MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 30: POLAND MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 31: REST OF EUROPE MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 32: ASIA-PACIFIC MALE INFERTILITY MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN%)

FIGURE 33: CHINA MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 34: JAPAN MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 35: INDIA MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 36: SOUTH KOREA MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 37: INDONESIA MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 38: THAILAND MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 39: VIETNAM MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 40: AUSTRALIA & NEW ZEALAND MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 41: REST OF ASIA-PACIFIC MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 42: REST OF WORLD MALE INFERTILITY MARKET, REGIONAL OUTLOOK, 2022 & 2032 (IN %)

FIGURE 43: LATIN AMERICA MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)

FIGURE 44: MIDDLE EAST & AFRICA MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)

FAQ’s

FAQs

The North America male infertility market size was valued at $1224.73 million in 2022.

DNA fragmentation technique held the highest market share in 2022.

Assisted reproductive technology and surgery is the fastest-growing treatment in the global male infertility market.

Request Customization
Request Customization
Request free sample